First Horizon Declares Quarterly Dividends
Apr 24, 2018 20:15 pm UTC| Business
MEMPHIS, Tenn., April 24, 2018 -- First Horizon National Corp.'s (NYSE:FHN) board of directors has approved payment of a quarterly cash dividend on its common stock of $.12 per share. The dividend is payable July 2,...
Supernus to Host First Quarter 2018 Earnings Conference Call
Apr 24, 2018 20:15 pm UTC| Business
ROCKVILLE, Md., April 24, 2018 -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS)...
KAR Auction Services, Inc. to Announce First Quarter 2018 Earnings
Apr 24, 2018 20:15 pm UTC| Business
CARMEL, Ind., April 24, 2018 -- KAR Auction Services, Inc. (NYSE:KAR) announced today that it will be releasing its first quarter 2018 earnings on Tuesday, May 8, 2018. KAR Auction Services, Inc. will also be hosting...
Apr 24, 2018 20:15 pm UTC| Business
DENVER, April 24, 2018 -- RLH Corporation (NYSE:RLH) announced today that it will report first quarter earnings results at 3:00 p.m. Eastern Time on May 8. Hosting the call will be RLH Corporation President Chief...
Superior Energy Services Announces First Quarter 2018 Results
Apr 24, 2018 20:15 pm UTC| Business
HOUSTON, April 24, 2018 -- Superior Energy Services, Inc. (the “Company”) today announced a net loss from continuing operations for the first quarter of 2018 of $59.9 million, or $0.39 per share, on revenue of $482.3...
DCP Midstream Announces Distributions on Its Common Units and Series A Preferred Units
Apr 24, 2018 20:15 pm UTC| Business
DENVER, April 24, 2018 -- DCP Midstream, LP (NYSE:DCP) announced today that the board of directors of its general partner declared a first quarter 2018 common unit distribution of $0.78 per unit, or $3.12 per unit on an...
Apr 24, 2018 20:15 pm UTC| Business
IRVING, Texas, April 24, 2018 -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (Reata or Company), a clinical-stage biopharmaceutical company, today announced new preclinical data demonstrating that omaveloxolone potently...